Autolus Therapeutics Ltd (AUTL) earnings · rev $75.4M
These earnings events as JSON? API free 100/dayAutolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
This AUTL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AUTL revenue for 2025-12-31 was $75.4M. Net income was -$287.5M. Revenue was up 644.9% from 2024-12-31 to 2025-12-31. AUTL currently screens at market cap $614.8M.
When the next AUTL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 644.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AUTL research stays on the stock page; the tape stays on the quote page.
AUTL earnings FAQ
What are AUTL's latest revenue and net income?
Latest cached Autolus Therapeutics Ltd (AUTL) revenue for Dec 31, 2025 was $75.4M. Net income was -$287.5M. Statements: https://lician.com/financials/autl
What is AUTL's latest diluted EPS?
Latest cached Autolus Therapeutics Ltd (AUTL) diluted EPS for Dec 31, 2025 was -$1.08.
What period does the latest AUTL earnings print cover?
The latest cached Autolus Therapeutics Ltd (AUTL) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did AUTL revenue change from the prior cached period?
Cached Autolus Therapeutics Ltd (AUTL) revenue was up 644.9% from $10.1M (Dec 31, 2024) to $75.4M (Dec 31, 2025). Statements: https://lician.com/financials/autl
Where are AUTL earnings listed?
Cached earnings facts for Autolus Therapeutics Ltd (AUTL) are listed at https://lician.com/earnings/autl. Statements: https://lician.com/financials/autl
Not investment advice.